{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-066058","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.955596+00:00","generated_at":"2026-06-01T07:34:46.680845+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rigel shareholders approve reverse stock split (1:2–1:20) and 6.5M share increase for equity plan","bullets":["Reverse stock split of common stock at ratio between 1:2 and 1:20 approved; 87.85M for, 42.50M against.","Amended 2018 Equity Incentive Plan authorized additional 6.5M shares; 53.15M for, 48.24M against.","Two directors elected: Brian L. Kotzin (78.45M for) and Gregg A. Lapointe (79.15M for) to terms until 2027.","Advisory say-on-pay approved (74.74M for, 26.22M against); Ernst & Young ratified as auditor for FY2024.","Adjournment proposal passed (83.11M for) to allow further solicitation if needed for reverse split."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-066058","json":"https://secwatch.observer/filing/0001104659-24-066058.json","markdown":"https://secwatch.observer/filing/0001104659-24-066058.md","text":"https://secwatch.observer/filing/0001104659-24-066058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924066058/0001104659-24-066058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924066058/tm2415798d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:34:46.680845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}